These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17431427)

  • 1. Antagonism of p66shc by melanoma inhibitory activity.
    Kasuno K; Naqvi A; Dericco J; Yamamori T; Santhanam L; Mattagajasingh I; Yang S; Meyskens FL; Bosserhoff AK; Irani K
    Cell Death Differ; 2007 Aug; 14(8):1414-21. PubMed ID: 17431427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina.
    Wu Z; Rogers B; Kachi S; Hackett SF; Sick A; Campochiaro PA
    J Cell Physiol; 2006 Dec; 209(3):996-1005. PubMed ID: 16972253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor phosphorylates protein kinase C {delta} at Tyr332 to form a trimeric complex with p66Shc in the H2O2-stimulated cells.
    Morita M; Matsuzaki H; Yamamoto T; Fukami Y; Kikkawa U
    J Biochem; 2008 Jan; 143(1):31-8. PubMed ID: 17956904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress.
    Khanday FA; Yamamori T; Mattagajasingh I; Zhang Z; Bugayenko A; Naqvi A; Santhanam L; Nabi N; Kasuno K; Day BW; Irani K
    Mol Biol Cell; 2006 Jan; 17(1):122-9. PubMed ID: 16251354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sos-mediated activation of rac1 by p66shc.
    Khanday FA; Santhanam L; Kasuno K; Yamamori T; Naqvi A; Dericco J; Bugayenko A; Mattagajasingh I; Disanza A; Scita G; Irani K
    J Cell Biol; 2006 Mar; 172(6):817-22. PubMed ID: 16520382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p66shc adaptor protein controls oxidative stress response and life span in mammals.
    Migliaccio E; Giorgio M; Mele S; Pelicci G; Reboldi P; Pandolfi PP; Lanfrancone L; Pelicci PG
    Nature; 1999 Nov; 402(6759):309-13. PubMed ID: 10580504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity.
    Yamamori T; Mizobata A; Saito Y; Urano Y; Inanami O; Irani K; Noguchi N
    Free Radic Res; 2011 Mar; 45(3):342-50. PubMed ID: 21047172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity.
    Smith WW; Norton DD; Gorospe M; Jiang H; Nemoto S; Holbrook NJ; Finkel T; Kusiak JW
    J Cell Biol; 2005 Apr; 169(2):331-9. PubMed ID: 15837797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
    Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
    EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-based Drug Development and Improvement Against Malignant Melanoma - Implications for the MIA Protein Family.
    Arnolds O; Zhong X; Tuo Yip K; Schöpel M; Kohl B; Pütz S; Abdel-Jalil R; Stoll R
    Curr Med Chem; 2017; 24(17):1788-1796. PubMed ID: 28595551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma.
    Marr DG; Poser I; Shellman YG; Bosserhoff AK; Norris DA
    Int J Oncol; 2004 Jul; 25(1):105-11. PubMed ID: 15201995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction.
    Yamamori T; White AR; Mattagajasingh I; Khanday FA; Haile A; Qi B; Jeon BH; Bugayenko A; Kasuno K; Berkowitz DE; Irani K
    J Mol Cell Cardiol; 2005 Dec; 39(6):992-5. PubMed ID: 16242150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.
    Stoll R; Renner C; Zweckstetter M; Brüggert M; Ambrosius D; Palme S; Engh RA; Golob M; Breibach I; Buettner R; Voelter W; Holak TA; Bosserhoff AK
    EMBO J; 2001 Feb; 20(3):340-9. PubMed ID: 11157741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis.
    Trinei M; Giorgio M; Cicalese A; Barozzi S; Ventura A; Migliaccio E; Milia E; Padura IM; Raker VA; Maccarana M; Petronilli V; Minucci S; Bernardi P; Lanfrancone L; Pelicci PG
    Oncogene; 2002 May; 21(24):3872-8. PubMed ID: 12032825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Amyloid-evoked apoptotic cell death is mediated through MKK6-p66shc pathway.
    Bashir M; Parray AA; Baba RA; Bhat HF; Bhat SS; Mushtaq U; Andrabi KI; Khanday FA
    Neuromolecular Med; 2014 Mar; 16(1):137-49. PubMed ID: 24085465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p66shc protein: a mediator of the programmed death of an organism?
    Skulachev VP
    IUBMB Life; 2000 Mar; 49(3):177-80. PubMed ID: 10868907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis.
    Giorgio M; Migliaccio E; Orsini F; Paolucci D; Moroni M; Contursi C; Pelliccia G; Luzi L; Minucci S; Marcaccio M; Pinton P; Rizzuto R; Bernardi P; Paolucci F; Pelicci PG
    Cell; 2005 Jul; 122(2):221-33. PubMed ID: 16051147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
    Jachimczak P; Apfel R; Bosserhoff AK; Fabel K; Hau P; Tschertner I; Wise P; Schlingensiepen KH; Schuler-Thurner B; Bogdahn U
    Int J Cancer; 2005 Jan; 113(1):88-92. PubMed ID: 15386421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.